Investment
Features
FeesSafety
Academy
More
Pluang+

TULSA Procedure shows strong clinical results and platform expansion potential at iMRI Symposium

Market News
14 Oct 2026
GlobeNewsWire
View Source
Bullish
TULSA Procedure shows strong clinical results and platform expansion potential at iMRI Symposium

Profound Medical presented five abstracts at the 15th Interventional MRI Symposium highlighting the TULSA Procedure's real-world effectiveness, clinical benefits, and potential for broader adoption. Studies from Mayo Clinic and the CARE Registry showed favorable patient outcomes including high rates of continence and erectile function preservation. The CAPTAIN trial demonstrated superior functional results compared to robotic prostatectomy. Additionally, technical validation on a lower-field Siemens MRI system suggests future expansion possibilities. These findings support TULSA's growing role in prostate cancer treatment and its potential to reach more patients with reduced infrastructure barriers.

The TULSA Procedure and its clinical advancements are highlighted here, with Pluang's health sector market data providing context. For readers following health-sector stocks, as of Oct 14, 2026 18:11 WIB, 103 of 150 priced US health stocks rose while 40 fell. Notable movers include Guardant Health Inc. (GH) at USD 158.20 with a 2.40% decrease and 100% buy order activity, Arrowhead Pharmaceuticals Inc. (ARWR) at USD 59.44 with a 2.25% increase, and Ginkgo Bioworks Holdings Inc. (DNA) at USD 12.02 with a 2.21% increase and a near-even buy/sell split.

More News

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global wins Best AI Solution for Software Development at 2026 AI in Capital Markets Awards

Genesis Global won the Best AI Solution for Software Development award at the 2026 AI in Capital Markets Awards for its product Genesis Create. This software combines AI with reusable components and financial expertise to help firms develop productio...

Others
Bullish
1 hour ago
nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz named Accelerator in 2026 Nucleus Research TMS Value Matrix for last-mile delivery tech

nuVizz has been recognized as an Accelerator in the 2026 Nucleus Research Transportation Management Value Matrix for its specialized last-mile delivery technology. The platform excels in coordinating complex delivery networks involving private fleets...

Market News
Bullish
1 hour ago
ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...

Company Fundamentals
Bullish
2 hours ago
Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...

Company Fundamentals
Bullish
2 hours ago
TSOs prioritize software investments to boost grid security and capacity amid rising demand

TSOs prioritize software investments to boost grid security and capacity amid rising demand

Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App